Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nimbolide targets RNF114 to induce the trapping of PARP1 and synthetic lethality in BRCA -mutated cancer
Peng Li, Yuanli Zhen, Chiho Kim, et al.
Science Advances (2023) Vol. 9, Iss. 43
Open Access | Times Cited: 20

Showing 20 citing articles:

Ubiquitin is directly linked via an ester to protein-conjugated mono-ADP-ribose
Daniel S. Bejan, Rachel E. Lacoursiere, Jonathan N. Pruneda, et al.
The EMBO Journal (2025)
Open Access | Times Cited: 3
EIF4A3‐Mediated Biogenesis of CircFADS1 Promotes the Progression of Hepatocellular Carcinoma via Wnt/β‐Catenin Pathway
Lei Tang, Yang Ji, Chuangye Ni, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Aberrant expression of NEDD4L disrupts mitochondrial homeostasis by downregulating CaMKKβ in diabetic kidney disease
Fei Han, Shi Wu, Ya Dong, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
DNA-PK participates in pre-rRNA biogenesis independent of DNA double-strand break repair
Peng Li, Xiaochen Gai, Qilin Li, et al.
Nucleic Acids Research (2024) Vol. 52, Iss. 11, pp. 6360-6375
Open Access | Times Cited: 4
Positioning Loss of PARP1 Activity as the Central Toxic Event in BRCA-Deficient Cancer
Nathan J. MacGilvary, Sharon B. Cantor
DNA repair (2024) Vol. 144, pp. 103775-103775
Open Access | Times Cited: 4
Epigenome-wide analysis reveals potential biomarkers for radiation-induced toxicity risk in prostate cancer
Carlos Lopez-Pleguezuelos, Miguel E. Aguado‐Barrera, Ana M. Carballo, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access
RNF114 Interacts with EWSR1 to Regulate VEGFR2 in HER2-positive Breast Cancer
Yingchuan Zhu, Yue Song, Yilu Lu, et al.
Journal of Cancer (2025) Vol. 16, Iss. 6, pp. 1888-1904
Open Access
PARP Inhibitors in the Neoadjuvant Setting; A Comprehensive Overview of the Rationale for their Use, Past and Ongoing Clinical Trials
Minatoullah Habaka, Gordon R. Daly, Deborah Shinyanbola, et al.
Current Oncology Reports (2025)
Open Access
Multi-omics analysis identifies diagnostic circulating biomarkers and potential therapeutic targets, revealing IQGAP1 as an oncogene in gastric cancer
Chao Deng, Chenjun Xie, Zhenhong Li, et al.
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access
Limonoids and semisynthetic derivatives as anticancer agents: Recent research progress and future perspectives
Qihui Wang, Bo Kou, Jingze Wang, et al.
Bioorganic Chemistry (2025) Vol. 161, pp. 108520-108520
Closed Access
Protein degraders - from thalidomide to new PROTACs
Takumi Ito
The Journal of Biochemistry (2023) Vol. 175, Iss. 5, pp. 507-519
Open Access | Times Cited: 10
PARticular MARks: Histone ADP-ribosylation and the DNA Damage Response
Cem Özdemir, Laura R. Purkey, Anthony Sanchez, et al.
DNA repair (2024) Vol. 140, pp. 103711-103711
Closed Access | Times Cited: 3
Plants Utilize a Protection/Deprotection Strategy in Limonoid Biosynthesis: A “Missing Link” Carboxylesterase Boosts Yields and Provides Insights into Furan Formation
Hannah Hodgson, Michael J. Stephenson, Shingo Kikuchi, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 43, pp. 29305-29310
Open Access | Times Cited: 2
Emerging strategies to overcome PARP inhibitors' resistance in ovarian cancer
Rui Bi, Li Chen, Mei Huang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189221-189221
Open Access | Times Cited: 2
Synthesis of nimbolide and its analogues and their application as poly(ADP-ribose) polymerase-1 trapping inducers
Heping Deng, Hejun Deng, Chiho Kim, et al.
Nature Synthesis (2023) Vol. 3, Iss. 3, pp. 378-385
Open Access | Times Cited: 5
An E3 ubiquitin ligase localization screen uncovers DTX2 as a novel ADP-ribosylation-dependent regulator of DNA double-strand break repair
Billel Djerir, Isabelle Marois, Jean-Christophe Dubois, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 8, pp. 107545-107545
Open Access | Times Cited: 1
Development of natural product-based targeted protein degraders as anticancer agents
Cheng Chen, Yanyan Feng, Chen Zhou, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107772-107772
Closed Access | Times Cited: 1
Nimbolide: A Potential Phytochemical Agent in Multimodal Pancreatic Cancer Therapies
Mukesh K. Jogi, Hitakshi Asnani, Sohini Singh, et al.
Mini-Reviews in Medicinal Chemistry (2024) Vol. 25, Iss. 1, pp. 27-41
Closed Access
Discovery of ester-linked ubiquitylation of PARP10 mono-ADP-ribosylation in cells: a dual post-translational modification on Glu/Asp side chains
Daniel S. Bejan, Rachel E. Lacoursiere, Jonathan N. Pruneda, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Recent Advances in Developing Targeted Protein Degraders
Binbin Cheng, Hongqiao Li, Xiaopeng Peng, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117212-117212
Closed Access
Page 1

Scroll to top